EA200700484A1 - Фармацевтическая композиция толтеродина с пролонгированным высвобождением - Google Patents

Фармацевтическая композиция толтеродина с пролонгированным высвобождением

Info

Publication number
EA200700484A1
EA200700484A1 EA200700484A EA200700484A EA200700484A1 EA 200700484 A1 EA200700484 A1 EA 200700484A1 EA 200700484 A EA200700484 A EA 200700484A EA 200700484 A EA200700484 A EA 200700484A EA 200700484 A1 EA200700484 A1 EA 200700484A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
tlterodin
prolonged delivery
sustained release
release pharmaceutical
Prior art date
Application number
EA200700484A
Other languages
English (en)
Inventor
Андрейка Крамер
Роберт Писек
Тадея Райер
Original Assignee
Крка, Д.Д. Ново Место
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34926332&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200700484(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Крка, Д.Д. Ново Место filed Critical Крка, Д.Д. Ново Место
Publication of EA200700484A1 publication Critical patent/EA200700484A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Настоящее изобретение относится к фармацевтической композиции с пролонгированным высвобождением, включающей толтеродин, предпочтительно толтеродина тартрат, к применению указанной композиции для приготовления лекарственного средства и к способу получения такой фармацевтической композиции с пролонгированным высвобождением.
EA200700484A 2004-08-27 2005-08-23 Фармацевтическая композиция толтеродина с пролонгированным высвобождением EA200700484A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04020431A EP1629834A1 (en) 2004-08-27 2004-08-27 Sustained release pharmaceutical composition of tolterodine
PCT/EP2005/009102 WO2006021425A1 (en) 2004-08-27 2005-08-23 Sustained release pharmaceutical composition of tolterodine

Publications (1)

Publication Number Publication Date
EA200700484A1 true EA200700484A1 (ru) 2007-10-26

Family

ID=34926332

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200700484A EA200700484A1 (ru) 2004-08-27 2005-08-23 Фармацевтическая композиция толтеродина с пролонгированным высвобождением

Country Status (7)

Country Link
EP (3) EP1629834A1 (ru)
AT (1) ATE505187T1 (ru)
DE (1) DE602005027469D1 (ru)
EA (1) EA200700484A1 (ru)
NO (1) NO20071299L (ru)
UA (1) UA87515C2 (ru)
WO (1) WO2006021425A1 (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0708848A2 (pt) * 2006-03-21 2011-06-21 Teva Pharma formulação de liberação controlada de tolterodina
EP1839649A1 (en) 2006-03-31 2007-10-03 LEK Pharmaceuticals D.D. Coated formulations for tolterodine
KR100851033B1 (ko) * 2007-02-12 2008-08-12 명문제약주식회사 엘-주석산 톨터로딘 함유 서방성 제제의 제조방법
US8871275B2 (en) 2007-08-08 2014-10-28 Inventia Healthcare Private Limited Extended release compositions comprising tolterodine
WO2011061616A2 (en) 2009-11-23 2011-05-26 Micro Labs Limited Extended release compositions containing tolterodine and process for preparing the same
WO2011095388A1 (en) 2010-02-04 2011-08-11 Synthon Bv Tolterodine bead
SG174658A1 (en) 2010-04-01 2011-10-28 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
CA2835277A1 (en) 2011-05-10 2012-11-15 Theravida, Inc. Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder
CN103211784B (zh) * 2012-01-18 2017-07-11 北京天衡药物研究院有限公司 酒石酸托特罗定膜控缓释微丸胶囊
TW201422254A (zh) 2012-11-21 2014-06-16 Ferring Bv 用於速釋及延釋的組成物
KR102600541B1 (ko) 2016-01-20 2023-11-08 테라비다, 인코포레이티드 다한증을 치료하기 위한 방법 및 조성물

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE2061C1 (ru) † 1890-01-25
SE8800207D0 (sv) 1988-01-22 1988-01-22 Kabivitrum Ab Nya aminer, deras anvendning och framstellning
SE9203318D0 (sv) 1992-11-06 1992-11-06 Kabi Pharmacia Ab Novel 3,3-diphenylpropylamines, their use and preparation
US6274171B1 (en) † 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
AU728395B2 (en) 1996-07-19 2001-01-11 Gunnar Aberg S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
KR20000057548A (ko) 1996-12-13 2000-09-25 알프레드 엘. 미첼슨 광학적 전송물질 및 결합재
SE9803871D0 (sv) 1998-11-11 1998-11-11 Pharmacia & Upjohn Ab Therapeutic method and formulation
NZ504618A (en) * 1998-08-27 2002-09-27 Pharmacia & Upjohn Ab Controlled release therapeutic formulation for administering tolterodine maintaining a constant serum level
DE19901692C2 (de) † 1999-01-18 2002-06-20 Gruenenthal Gmbh Verfahren zur Herstellung von Pellets mit einem Gehalt von bis zu 90 Gew.% eines pharmazeutischen Wirkstoffes
EE05191B1 (et) † 1999-11-11 2009-08-17 Pharmacia Ab Farmatseutiline kompositsioon, mis sisaldab tolterodiini, ja selle kasutamine
SE9904850D0 (sv) 1999-12-30 1999-12-30 Pharmacia & Upjohn Ab Novel process and intermediates
IN191835B (ru) 2001-08-03 2004-01-10 Ranbaxy Lab Ltd
US20030185882A1 (en) * 2001-11-06 2003-10-02 Vergez Juan A. Pharmaceutical compositions containing oxybutynin
AU2002360717A1 (en) * 2001-12-20 2003-07-09 Pharmacia Corporation Controlled release dosage form having improved drug release properties
KR100540035B1 (ko) † 2002-02-01 2005-12-29 주식회사 태평양 다단계 경구 약물 방출 제어 시스템
US7005449B2 (en) 2002-04-23 2006-02-28 Pharmacia & Upjohn Company Tolterodine salts
CN1150160C (zh) 2002-04-29 2004-05-19 上海医药工业研究院 L－酒石酸托特罗定的合成方法
WO2004105735A1 (en) 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Controlled release pharmaceutical compositions of tolterodine and processes for their preparation

Also Published As

Publication number Publication date
WO2006021425A1 (en) 2006-03-02
ATE505187T1 (de) 2011-04-15
EP1781275B1 (en) 2011-04-13
EP1964553A1 (en) 2008-09-03
EP1629834A1 (en) 2006-03-01
NO20071299L (no) 2007-05-29
EP1781275A1 (en) 2007-05-09
DE602005027469D1 (de) 2011-05-26
UA87515C2 (ru) 2009-07-27
EP1781275B2 (en) 2014-04-16

Similar Documents

Publication Publication Date Title
EA200700484A1 (ru) Фармацевтическая композиция толтеродина с пролонгированным высвобождением
LTC1781298I2 (lt) Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui
CY1112320T1 (el) Τιτλοδοτηση της ταπενταδολης
MX2020008616A (es) Rocio de fentanilo sublingual.
CL2009000349A1 (es) Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer.
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
IL183360A (en) 12-aryl prostaglandin analogs, compositions comprising them and their use in the preparation of medicaments
RS52169B (en) STABLE LAKVINIMOD PREPARATIONS
SMT201200014B (it) Nalmefene cloridrato diidrato.
WO2006119389A3 (en) Quinine-containing controlled-release formulations
CL2008002162A1 (es) Compuestos derivados de 3-benzoisoxazol-piperidin; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento y/o prevencion de trastornos cognitivos, adiccion a drogas, depresion, ansiedad, entre otras.
EA200702522A1 (ru) Система доставки лекарств в полость рта и способы ее применения
MY153408A (en) Novel methods
AR060019A1 (es) Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo
CR8371A (es) Formulaciones de medicamento que contienen saborizantes con mejores propiedades farmaceuticas
CR10305A (es) "derivados sustituidos de cromanol y su uso.
WO2007056142A3 (en) Methods of preventing the serotonin syndrome and compositions for use therefor
EA201170512A1 (ru) Композиция для перорального введения
ATE503491T1 (de) Verbesserte anthraximpfstoffe und abgabeverfahren
CR7271A (es) Formulaciones farmaceuticas novedosas a base de melatonina y compuestos similares para su uso en transtornos del sueno
ATE541573T1 (de) Pharmazeutische zusammensetzung enthaltend lapatinib
GEP20115158B (en) Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunction
GB2443377A (en) Anti-malarial composition comprising artesunate and lumefantrine
HN2003000104A (es) Derivados de ciclopenteno
BRPI0409175A (pt) preparação farmacêutica oral para antagonistas de bombeamento de próton